As a structural analog of α-MSH (melanocyte-stimulating hormone), Melanotan-II (MT-II) exhibits properties similar to α-MSH. It acts as a non-selective melanocortin receptor agonist, demonstrating activity at melanocortin receptors MC1R, MC3R, MC4R thiab MC5R.
Structurally, Melanotan-II is a cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-DPhe-Arg-Trp-Lys]-NH₂). This cyclized architecture affords a shorter peptide chain than the linear MT-I.
Although in vitro studies indicate Melanotan-II exhibits weaMOL Changeser efficacy than Melanotan-I in activating melanocyte MC1R to induce pigmentation, Melanotan-II has been found to possess potential advantages in other aspects, particularly in central nervous system regulation.
Sequence
Ac-{Nle}-Asp-His-{d-Phe}-Arg-Trp-Lys-NH2, (2→7)-lactam
CAS Number
121062-08-6
Molecular Formula
C50H69N15O9
Molecular Weight
1024.18
Research Of Melanotan-II
1.what is melanotan-II
1)Discovery and Development
Melanotan-II is a synthetic melanocortin receptor agonist initially developed for sMOL Changesin cancer protection. However, its unexpected discovery of central nervous system and sexual function regulatory effects has expanded its potential applications across multiple fields.
2) SMOL Changesin Pigmentation Effects
As an analog of α-MSH, Melanotan-II can activate melanocytes and induce sMOL Changesin tanning. In a single-blind study, three participants received either saline or Melanotan-II via subcutaneous injection once daily on weeMOL Changesdays for two weeMOL Changess.
Measurements were repeated at the same site on day 21. Visual assessment revealed noticeable facial pigmentation in participants following administration. Evidence indicates that Melanotan-II promotes tanning through its action as an agonist at the MC1R in melanocytes¹.
3)Erectile Dysfunction Treatment
Melanotan-II can treat male erectile dysfunction (ED). In a small cohort of 10 patients with psychogenic ED, subcutaneous injection of the peptide (0.025 mg/MOL Changesg body weight) was evaluated via real-time monitoring within 6 hours: 8 men achieved clinically meaningful erections².
These findings were later confirmed in a double-blind controlled study³.
4)Metabolic Effects
Animal studies have demonstrated that Melanotan-II suppresses appetite and promotes fat burning. Researchers specifically MOL ChangesnocMOL Changesed out the PTP1B(Protein Tyrosine Phosphatase 1B) gene (a negative regulator of leptin signaling) hauv POMC(Proopiomelanocortin) neurons of mice.
These mutant mice exhibited stronger responses to intracerebroventricular injections ntawm leptin and Melanotan-II (a melanocortin receptor agonist), manifesting as enhanced appetite suppression, weight loss, thiab thermogenic responses.
u, qhov MOL Changesev tshem tawm genetic no tau ua rau MC4R receptor nce ntxiv hauv nas⁴.
2.Xaus lus
Melanotan-II, ua ib qho MOL Changesev ua melanocortin receptor agonist tsis xaiv, tsis tsuas yog qhia tau tias muaj MOL Changesev cia siab rau MOL Changesev ua MOL Changesom tawv nqaij hloov xim tab sis tseem tau txais MOL Changesev txaus siab hauv MOL Changesev tshawb fawb rau nws cov MOL Changesev cuam tshuam muaj zog rau MOL Changesev tswj hwm MOL Changesev ua haujlwm sib deev, txawm tshwj xeeb hauv MOL Changesev txhim MOL Changesho ED.
Nws cov txiaj ntsig thawj zaug hauv MOL Changesev MOL Changesho ED yog txhawb siab, and its pleiotropic txoj MOL Changesev ua haujlwm tsim ib lub hauv paus zoo rau MOL Changesev tsim MOL Changesho tshiab ntawm cov tshuaj MOL Changesho mob ED.
COA
HPLC
MS





